Ming Jiang
About
I had trained as a postdoctoral associate in Professor Pierre Chambon's Lab at IGBMC in France from 1999 to 2002, focusing on dissection of nuclear receptor RXRs and PPARs signaling pathways in the development and carcinogenesis in prostate, adipocyte, liver, and skin tissues and organs by an originally established inducible conditional Cre-ERT2/LoxP transgenic mouse model. I moved to Dr. Simon Hayward's Lab in Vanderbilt Prostate Cancer Center at Vanderbilt University Medical Center (VUMC), Nashville, TN, USA in 11/2002. I was promoted as a Research Assistant Professor of Urological Surgery in 2/2007 and then a Research Associate Professor of Medicine at VUMC in 1/2015. I am currently a Research Assistant Professor in Dr. Michael Savona's Lab in the Division of Hematology and Oncology, Department of Medicine at Vanderbilt-Ingram Cancer Center (VICC), VUMC. I am working on hematopoiesis and the biology of myeloid diseases including acute myeloid leukemia (AML), focusing on the research and development of novel oxidative phosphorylation (OxPhos) inhibitors in AML clinical. I am a biomedical research scientist special in cancer biopathology and translational medicine with extensive skills in establishment and characterization of primary culture cells, immortalized cell lines, 3D-organoid culture, patient-derived xenografting (PDX), and tissue recombination-xenografting (TRX) models in prostate, bladder, colorectal, and lung organs.